GENEMEDICS APP
GENEMEDICS NUTRITION
OTR-AC benefits include promoting muscle growth and strength while simultaneously reducing body fat, making it a powerful compound for body composition improvement. Additionally, it supports bone health, helps lower cholesterol levels, and improves blood sugar regulation, contributing to overall metabolic wellness.
OTR-AC, also known as MK-2866 Ester, is a modified form of Ostarine, a selective androgen receptor modulator (SARM). This esterified version is designed to enhance potency, extend its half-life, and maintain stable blood levels for a longer duration. It is commonly used to promote muscle growth, increase strength, reduce body fat, and support bone health. The extended activity of OTR-AC allows for less frequent dosing compared to regular Ostarine. While it offers potential performance benefits, it may also pose risks such as liver strain and cardiovascular issues, making professional medical guidance important before use.
OTR-AC works by selectively binding to androgen receptors in muscle and bone tissues, stimulating anabolic activity while minimizing the side effects typically associated with traditional anabolic steroids. Its esterified structure extends its half-life, allowing it to remain active in the body for a longer period, resulting in more sustained muscle growth and enhanced recovery. By activating androgen receptors, OTR-AC increases protein synthesis and nitrogen retention, which are essential for building and maintaining lean muscle mass. This targeted action also helps improve bone density and reduce body fat without significantly affecting other tissues, making it a popular choice for those seeking muscle enhancement with fewer side effects.
OTR-AC, an esterified form of the selective androgen receptor modulator (SARM) ostarine, enhances muscle mass and strength by selectively binding to androgen receptors in muscle and bone tissues. This selective binding stimulates protein synthesis and reduces protein breakdown, leading to increased muscle growth and strength. The esterification process extends OTR-AC’s half-life, enhancing its potency and bioavailability, which contributes to its effectiveness in promoting lean muscle mass while minimizing fat accumulation.
OTR-AC, a compound in some studies, is believed to reduce body fat through its effects on metabolism and fat cell regulation. It works by activating specific receptors that influence the breakdown of fat (lipolysis) and the regulation of fat storage. OTR-AC may also enhance thermogenesis, which increases calorie burning, and improve insulin sensitivity, helping the body use fat more efficiently for energy. These combined actions can lead to a reduction in overall body fat. However, more research is needed to fully understand its mechanisms and long-term effects.
OTR-AC, an esterified form of the selective androgen receptor modulator (SARM) Ostarine, enhances bone health by binding to androgen receptors in bone tissue, thereby stimulating bone formation and increasing bone mineral density. This targeted action helps prevent bone disorders such as osteoporosis. Studies have demonstrated that OTR-AC improves bone healing, increases bone volume and density, and accelerates osteotomy healing in animal models.
OTR-AC, an esterified form of the selective androgen receptor modulator (SARM) ostarine, has been observed to lower cholesterol levels, particularly low-density lipoprotein (LDL) cholesterol, in both animal studies and limited human trials. In elderly men and postmenopausal women, OTR-AC administration resulted in significant reductions in LDL levels.
OTR-AC, an esterified form of the selective androgen receptor modulator (SARM) ostarine, has demonstrated potential in improving blood sugar regulation. Clinical studies involving elderly men and postmenopausal women have shown that OTR-AC administration led to reductions in fasting blood glucose levels and insulin resistance, while concurrently increasing muscle mass. The precise mechanisms by which OTR-AC enhances insulin sensitivity are not fully elucidated; however, its ability to increase muscle mass may play a role, as greater muscle mass can enhance glucose uptake and utilization. Additionally, OTR-AC has been associated with reductions in body fat, which may further contribute to improved insulin sensitivity and blood sugar control. While these findings are promising, further research is necessary to fully understand the mechanisms and long-term effects of OTR-AC on glucose metabolism.
OTR-AC side effects are very uncommon. Some users have reported experiencing certain issues while using this SARM, but these effects were not conclusively linked to the treatment and could have occurred coincidentally. Despite this, they have been listed as potential side effects for awareness.
Side effects associated with OTR-AC may include the following:
While these effects are rare, individuals should monitor their response and consult a healthcare professional if they experience any concerns.
OTR-AC vs. RAD-140: Mechanism and Purpose
OTR-AC and RAD-140 are both selective androgen receptor modulators (SARMs), but they serve slightly different purposes. OTR-AC is known for its enhanced bioavailability and sustained release, allowing for better absorption and prolonged effects. It is commonly used to promote lean muscle retention, improve bone density, and support recovery. RAD-140, also known as Testolone, is a more potent SARM primarily used for increasing muscle mass and strength, making it popular in bulking cycles. Both compounds bind to androgen receptors, but RAD-140 has a stronger anabolic effect compared to OTR-AC.
Effectiveness and Side Effects
When comparing effectiveness, RAD-140 is generally more powerful in building muscle quickly, while OTR-AC offers a more gradual and sustained anabolic effect.RAD-140ās potency may lead to greater side effects, such as testosterone suppression, liver toxicity, and potential hormonal imbalances. OTR-AC, with its controlled release, is designed to minimize sudden hormonal fluctuations, potentially reducing these risks. However, both compounds can impact natural testosterone production, requiring post-cycle therapy (PCT) to restore hormonal balance.
Suitability and Usage
OTR-AC is often preferred for those seeking moderate muscle gains with fewer side effects, making it suitable for beginners or those on cutting cycles. RAD-140 is better suited for advanced users looking for significant strength and muscle mass increases, especially in bulking phases. The choice between the two depends on individual goals, tolerance for potential side effects, and experience with SARMs. Both compounds should be used responsibly, with regular health monitoring and appropriate PCT to maintain hormonal health.
OTR-AC, an esterified form of the Selective Androgen Receptor Modulator (SARM) Ostarine, exhibits enhanced potency and a prolonged half-life compared to its non-esterified counterpart. This modification allows for more flexible dosing schedules, potentially improving user compliance and effectiveness.
Recommended dosing protocols for OTR-AC vary based on individual goals and experience levels. For men, typical dosages range from 15 to 30 mg daily, administered over cycles lasting 12 to 18 weeks. Women are generally advised to take between 5 and 15 mg daily, with cycle durations of 6 to 8 weeks. Some users have reported effective dosing at 25 to 50 mg every other day, owing to OTR-AC’s extended half-life.
To maximize absorption, it is recommended to take OTR-AC with a meal, maintaining consistent timing each day. Adherence to the prescribed dosing regimen is crucial to achieve desired outcomes while minimizing potential adverse effects. As with any performance-enhancing compound, consulting with a healthcare professional before beginning an OTR-AC cycle is advisable to ensure safe and effective use.
OTR-AC, also known as Ostarine O-Acetate, is a modified form of the Selective Androgen Receptor Modulator (SARM) Ostarine (MK-2866). Through a chemical process called esterification, Ostarine is combined with an acetate group, resulting in enhanced potency, increased half-life, and improved biodistribution.This modification allows OTR-AC to remain active in the body up to ten times longer than its non-esterified counterpart, making it a potent agent for muscle growth and fat reduction.
In its liquid form, OTR-AC offers greater bioavailability compared to other forms, such as capsules or powders. This means that when administered as a liquid, a higher proportion of the compound is absorbed into the bloodstream, potentially leading to more effective results. Users have reported significant increases in lean muscle mass and reductions in body fat when incorporating OTR-AC liquid into their fitness regimens.
Beyond its muscle-building and fat-loss benefits, OTR-AC has been associated with additional health advantages, including improved bone health, lowered cholesterol levels, and enhanced blood sugar regulation. However, it’s essential to approach the use of OTR-AC liquid with caution, as potential side effects and long-term impacts are not yet fully understood. Consulting with a healthcare professional before beginning any new supplement regimen is highly recommended to ensure safety and efficacy.
OTR-AC vs. Ostarine: Mechanism and Effectiveness
OTR-AC and ostarine (MK-2866) are both selective androgen receptor modulators (SARMs) known for promoting muscle growth and improving physical performance. While both compounds target androgen receptors to stimulate anabolic activity, OTR-AC is designed for enhanced bioavailability and sustained release. This means OTR-AC may deliver longer-lasting effects and better cellular absorption compared to traditional ostarine, potentially leading to more consistent muscle growth and strength gains over time.
Safety and Side Effects
Both OTR-AC and ostarine may cause hormonal suppression, particularly affecting natural testosterone levels. However, OTR-ACās improved delivery system could result in a more gradual impact on hormone balance, potentially reducing the severity of suppression. Both compounds may also stress the liver, with some users reporting elevated liver enzymes. As with any SARM, proper dosage, monitoring, and post-cycle therapy (PCT) are essential to minimize long-term health risks.
Usage and Application
Ostarine is widely used for muscle preservation during cutting phases, while OTR-ACās advanced formulation may offer more versatile applications, including bulking and maintaining lean mass. OTR-ACās sustained-release feature could provide smoother performance enhancements without the need for frequent dosing. For athletes and bodybuilders seeking greater efficiency and stability, OTR-AC may present an advantage over standard ostarine, though both compounds deliver comparable muscle-building benefits.
Selective Androgen Receptor Modulators (SARMs) are compounds designed to target androgen receptors in the body, promoting muscle growth and bone health without the widespread effects of traditional anabolic steroids. Unlike steroids, which affect multiple tissues, SARMs selectively bind to receptors in muscle and bone, reducing the risk of unwanted side effects. This makes them an appealing option for individuals looking to enhance physical performance and recovery.
Originally developed to treat muscle-wasting diseases, osteoporosis, and other conditions, SARMs have gained popularity in the fitness and bodybuilding communities. Their ability to support lean muscle growth, fat loss, and endurance has made them a sought-after alternative to conventional performance enhancers. However, ongoing research is still determining their long-term effects and safety.
Despite their benefits, SARMs are subject to regulation in many countries, and their use in professional sports is prohibited by organizations like the World Anti-Doping Agency (WADA). Some products marketed as SARMs may also contain unlisted ingredients, emphasizing the need for consumers to be cautious when purchasing supplements. As research continues, SARMs hold potential for medical use, but responsible usage and awareness remain crucial.
SARMs affect muscle tissue by selectively binding to androgen receptors in muscle cells, stimulating protein synthesis and promoting muscle growth. This targeted action helps increase lean muscle mass without significantly affecting other organs, reducing the risk of side effects commonly associated with anabolic steroids. By enhancing nitrogen retention and muscle fiber development, SARMs support faster recovery and improved muscle endurance.
In addition to muscle growth, SARMs help prevent muscle breakdown, making them beneficial for individuals recovering from injuries or dealing with muscle-wasting conditions. Their ability to increase anabolic activity in muscle tissue while minimizing androgenic effects in other areas of the body makes them a preferred choice for those looking to build strength without excessive hormonal disruptions. This is particularly advantageous for athletes and bodybuilders seeking lean gains.
Moreover, SARMs can enhance fat metabolism, contributing to a more defined and toned physique. By promoting the growth of lean muscle while reducing fat accumulation, they help users achieve a more sculpted appearance. Combined with proper training and nutrition, SARMs can be a powerful tool for those looking to optimize muscle development and overall body composition.
Ostarine (MK-2866) has been reported to promote lean muscle mass, support muscle recovery, and may aid in fat loss, contributing to a leaner physique.
Yes, ostarine can suppress natural testosterone production, especially at higher doses or with prolonged use. If you’re looking to buy otr ac, it’s important to be aware of these potential side effects. Many users who buy otr ac report experiencing hormonal changes, making post-cycle therapy (PCT) essential. Always research thoroughly before you buy otr ac to ensure safe and informed use.
Ostarine binds to androgen receptors, promoting muscle growth and bone density, making it popular among athletes and bodybuilders due to its role in protein synthesis.
Ostarine has been associated with elevated liver enzymes, indicating potential liver stress or damage, particularly with high doses or extended use. It is also used to combat muscle loss in certain medical conditions.
I’m sorry, but I need more context to answer this question accurately. Are you referring to air conditioning, a specific medical condition, anabolic agents, or something else?
Ostarine (MK-2866) is among the most researched SARMs, initially developed to combat muscle wasting and osteoporosis. Fitness enthusiasts are particularly interested in its potential to support muscle growth and recovery.
Yes, ostarine can suppress natural testosterone levels, potentially leading to hormonal imbalances and affecting potential benefits.
RAD140 (Testolone) may lead to gynecomastia (development of breast tissue in men) due to hormonal imbalances, although more research is needed to confirm this risk. Despite these concerns, some users explore RAD140 for its potential benefits in muscle growth and strength enhancement.
Research on RAD140 has shown neuroprotective properties, potentially supporting brain health and neuron survival. Additionally, research suggests it may also help increase bone density.
Research shows that RAD140 can suppress natural testosterone production, which may require post-cycle therapy to restore hormonal balance and support weight loss. Further research is needed to fully understand its long-term effects on hormone regulation.
RAD140 has been associated with liver toxicity, including elevated liver enzymes, indicating potential liver stress or damage due to its selective action.
Ostarine may cause liver toxicity, as indicated by elevated liver enzymes in some users, according to laboratory research.
Users often report noticing effects from ostarine within the first week, with more significant results typically observed after several weeks of consistent use. It is essential to follow the recommended dose to achieve optimal outcomes. Sticking to the recommended dose also helps minimize potential side effects while maximizing benefits.
Both ostarine and ligandrol (LGD-4033) are SARMs with muscle-building properties. Ostarine is often chosen for cutting phases due to its milder effects and its ability to provide more energy, while ligandrol is preferred for bulking because of its stronger anabolic properties. Many users report experiencing more energy when using these compounds during their fitness routines.
SARMs offer benefits such as increased muscle mass, improved bone density, enhanced physical performance, and potential fat loss, with fewer side effects compared to traditional anabolic steroids. Although SARMs are being researched for therapeutic purposes, they are not approved for human consumption. Despite this, some individuals still use SARMs for human consumption due to their perceived performance-enhancing effects.
SARMs can suppress natural hormone production, particularly testosterone, leading to potential hormonal imbalances. This suppression can negatively impact muscle and bone health over time. Additionally, disruptions in hormone levels may affect the maintenance of muscle and bone density.
Positive effects of SARMs include muscle growth, increased strength, improved bone density, and potential fat loss. These drug-like compounds are designed to target androgen receptors selectively. Some users turn to this drug for performance enhancement while aiming to minimize side effects.
Bhasin S. Selective Androgen Receptor Modulators as Function Promoting Therapies. J Frailty Aging. 2015;4(3):121-122. doi:10.14283/jfa.2015.65.
Selective Androgen Receptor Modulators as Function Promoting Therapies
Selective androgen receptor modulators (SARMs) are being developed to enhance muscle and bone health while minimizing risks to the prostate and cardiovascular system. Unlike traditional steroidal SARMs, newer nonsteroidal SARMs act as full agonists in muscle and bone but only partial agonists in the prostate, offering tissue-specific effects. Preclinical studies show increased muscle and bone mass with minimal prostate stimulation, and early human trials report modest gains in fat-free mass. SARMs show potential as anabolic therapies for aging-related conditions, frailty, cancer cachexia, and osteoporosis.
You can read the abstract of this article at
https://pubmed.ncbi.nlm.nih.gov/19357508/.
Dalton JT 2007 Development and potential uses of selective androgen receptor modulators (SARMs). American Society of Andrology.
Development and potential uses of selective androgen receptor modulators (SARMs)
Selective androgen receptor modulators (SARMs) offer a promising way to harness the androgen receptor’s (AR) benefits in a tissue-specific manner while minimizing side effects. Over the past two decades, extensive research has advanced SARMs from experimental agents to potential treatments for conditions like muscle-wasting, breast cancer, and osteoporosis, highlighting their therapeutic potential and mechanisms of action.
You can read the abstract of this article at
https://pubmed.ncbi.nlm.nih.gov/28624515/.
Dalton JT, Therapeutic promise of selective androgen receptor modulators (SARMs): preclinical and clinical proof-of-concept studies. Program of the 89th Annual Meeting of The Endocrine Society, Toronto, Canada, 2007 (Abstract 41-42).
Therapeutic promise of selective androgen receptor modulators (SARMs): preclinical and clinical proof-of-concept studies
Nonsteroidal selective androgen receptor modulators (SARMs) offer a promising alternative to traditional steroidal androgens for testosterone replacement, providing benefits like oral bioavailability, tissue selectivity, and fewer steroid-related side effects while maintaining key male characteristics such as muscle mass and spermatogenesis.
You can read the abstract of this article at
https://pubmed.ncbi.nlm.nih.gov/15994457/.
Steiner M. S.; Barnette K. G.; Hancock M. L.; Dodson S. T.; Rodriguez D.; Morton R. A. Effect of GTx-024, a selective androgen receptor modulator (SARM), on stair climb performance and quality of life (QOL) in patients with cancer cachexia. ASCO Meeting Abstracts 2010, 28, 9147.
Effect of GTx-024, a selective androgen receptor modulator (SARM), on stair climb performance and quality of life (QOL) in patients with cancer cachexia
A 12-week phase II trial of GTx-024 (enobosarm), a selective androgen receptor modulator (SARM), in elderly men and postmenopausal women showed significant, dose-dependent increases in lean body mass, improved physical function, and better insulin resistance with a favorable safety profile, suggesting its potential for treating muscle wasting in chronic diseases.
You can read the abstract of this article at
https://pubmed.ncbi.nlm.nih.gov/22031847/.
Zilbermint, M. F., & Dobs, A. S. (2009). Nonsteroidal selective androgen receptor modulator Ostarine in cancer cachexia. Future oncology (London, England), 5(8), 1211ā1220. https://doi.org/10.2217/fon.09.106.
Nonsteroidal selective androgen receptor modulator Ostarine in cancer cachexia
Cancer cachexia affects up to 60% of cancer patients in the USA, leading to weight loss, malnutrition, and increased mortality. Current treatments are often ineffective with significant side effects. Ostarine, a selective androgen receptor modulator, shows promise in increasing lean body mass and improving function with minimal side effects, but further research is needed to confirm its efficacy.
You can read the abstract of this article at
https://pubmed.ncbi.nlm.nih.gov/19852734/.
Zilbermint, M. F., & Dobs, A. S. (2009). Nonsteroidal selective androgen receptor modulator Ostarine in cancer cachexia. Future oncology (London, England), 5(8), 1211ā1220. https://doi.org/10.2217/fon.09.106.
Nonsteroidal selective androgen receptor modulator Ostarine in cancer cachexia
DUPLICATE
You can read the abstract of this article at
Dalton JT, Barnette KG, Bohl CE, Hancock ML, Rodriguez D, Dodson ST, Morton RA, Steiner MS. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial. J Cachexia Sarcopenia Muscle. 2011 Sep;2(3):153-161. doi: 10.1007/s13539-011-0034-6. Epub 2011 Aug 2. PMID: 22031847; PMCID: PMC3177038.
The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial
GTx-024 (enobosarm), a selective androgen receptor modulator, demonstrated significant dose-dependent increases in lean body mass, physical function, and insulin resistance in a 12-week phase II trial involving elderly men and postmenopausal women, with a favorable safety profile, suggesting potential for treating muscle wasting in chronic diseases.
You can read the abstract of this article at
https://pubmed.ncbi.nlm.nih.gov/22031847/.
Roch PJ, Henkies D, Carstens JC, Krischek C, Lehmann W, Komrakova M, Sehmisch S. Ostarine and Ligandrol Improve Muscle Tissue in an Ovariectomized Rat Model. Front Endocrinol (Lausanne). 2020 Sep 17;11:556581. doi: 10.3389/fendo.2020.556581. PMID: 33042018; PMCID: PMC7528560.
Ostarine and Ligandrol Improve Muscle Tissue in an Ovariectomized Rat Model. Front Endocrinol (Lausanne)
In ovariectomized rats modeling postmenopausal conditions, Ostarine (OS) and Ligandrol (LG) increased muscle capillary density, with OS having a stronger effect on vascularization and LG enhancing muscle metabolism. Neither SARM altered muscle fiber size, but both increased enzyme activity in specific muscles. However, higher doses led to uterotrophic effects, and LG (4 mg) increa.sed muscle weight and intramuscular fat, which may limit their therapeutic use at these dosages.
You can read the abstract of this article at
https://pubmed.ncbi.nlm.nih.gov/33042018/.
Leciejewska, N., KoÅodziejski, P. A., Sassek, M., Nogowski, L., MaÅek, E., & PruszyÅska-OszmaÅek, E. (2022). Ostarine-Induced Myogenic Differentiation in C2C12, L6, and Rat Muscles. International journal of molecular sciences, 23(8), 4404. https://doi.org/10.3390/ijms23084404.
Ostarine-Induced Myogenic Differentiation in C2C12, L6, and Rat Muscles
You can read the abstract of this article at
https://pubmed.ncbi.nlm.nih.gov/35457222/.
Solomon ZJ, Mirabal JR, Mazur DJ, Kohn TP, Lipshultz LI, Pastuszak AW. Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications. Sex Med Rev. 2019;7(1):84-94. doi:10.1016/j.sxmr.2018.09.006.
Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications
Selective androgen receptor modulators (SARMs) selectively bind to androgen receptors, promoting anabolic activity while minimizing side effects associated with traditional anabolic steroids. This review summarizes current research on SARMs, highlighting their pharmacokinetics, pharmacodynamics, and potential clinical applications in treating conditions like cachexia, hypogonadism, breast cancer, and benign prostatic hyperplasia (BPH). Although not yet approved by the FDA, early studies suggest SARMs may offer effective and safe therapeutic options for various medical conditions.
You can read the abstract of this article at
https://pubmed.ncbi.nlm.nih.gov/30503797/.
Narayanan R, Mohler ML, Bohl CE, Miller DD, Dalton JT. Selective androgen receptor modulators in preclinical and clinical development. Nucl Recept Signal. 2008;6:e010.
Selective androgen receptor modulators in preclinical and clinical development
Selective androgen receptor modulators (SARMs) are nonsteroidal compounds that bind to androgen receptors, promoting muscle and bone growth with minimal effects on prostate and other secondary sexual organs. They offer therapeutic potential for conditions like muscle wasting, osteoporosis, frailty, and hypogonadism. This review explores SARMs’ mechanisms, androgen receptor interactions, and their emerging medical applications.
You can read the abstract of this article at
https://pubmed.ncbi.nlm.nih.gov/19079612/.
Leciejewska, N., Pruszynska-Oszmalek, E., Bien, J., Nogowski, L., & Kolodziejski, P. A. (2019). Effect of ostarine (enobosarm/GTX024), a selective androgen receptor modulator, on adipocyte metabolism in Wistar rats. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 70(4), 10.26402/jpp.2019.4.04. https://doi.org/10.26402/jpp.2019.4.04.
Effect of ostarine (enobosarm/GTX024), a selective androgen receptor modulator, on adipocyte metabolism in Wistar rats
This study investigates the effects of ostarine (enobosarm), a nonsteroidal selective androgen receptor modulator (SARM), on rat adipocyte metabolism in vitro. Ostarine, like testosterone, influences lipid metabolism through androgen receptors, significantly reducing the expression and secretion of leptin and adiponectin. These findings highlight the potential of SARMs in treating androgen deficiency and underscore the need for further research on their systemic effects.
You can read the abstract of this article at
https://pubmed.ncbi.nlm.nih.gov/31642815/.
Komrakova M, FurtwƤngler J, Hoffmann DB, Lehmann W, Schilling AF, Sehmisch S. The Selective Androgen Receptor Modulator Ostarine Improves Bone Healing in Ovariectomized Rats. Calcif Tissue Int. 2020 Feb;106(2):147-157. doi: 10.1007/s00223-019-00613-1. Epub 2019 Sep 17. PMID: 31531719.
The Selective Androgen Receptor Modulator Ostarine Improves Bone Healing in Ovariectomized Rats
Ostarine, a non-steroidal selective androgen receptor modulator, improved early bone healing in ovariectomized rats by enhancing callus formation, increasing callus density, accelerating osteotomy bridging, and boosting alkaline phosphatase expression. While all ostarine doses increased muscle weight, only higher doses partially restored uterus weight and altered serum cholesterol and phosphorus levels. These findings suggest ostarine may be a potential treatment for osteoporosis, though its metabolic side effects require further investigation.
You can read the abstract of this article at
https://pubmed.ncbi.nlm.nih.gov/31531719/.
Komrakova M, Nagel J, Hoffmann DB, Lehmann W, Schilling AF, Sehmisch S. Effect of Selective Androgen Receptor Modulator Enobosarm on Bone Healing in a Rat Model for Aged Male Osteoporosis. Calcif Tissue Int. 2020;107(6):593-602. doi:10.1007/s00223-020-00751-x.
Effect of Selective Androgen Receptor Modulator Enobosarm on Bone Healing in a Rat Model for Aged Male Osteoporosis
This study compared the effects of enobosarm (EN) and testosterone (T) on bone healing in an orchiectomized rat model for aged male osteoporosis. Both T treatments improved bone healing without affecting prostate or levator ani weight, while EN prophylaxis (EN-pr) increased callus area and density but also raised prostate weight. EN therapy (EN-th) negatively affected bone healing by reducing callus density and delaying fracture repair. The study suggests T is more effective for bone healing, while EN treatment after fracture is not advisable due to potential negative effects and endocrine side effects.
You can read the abstract of this article at
https://pubmed.ncbi.nlm.nih.gov/32876707/.
Hoffmann DB, Komrakova M, Pflug S, et al. Evaluation of ostarine as a selective androgen receptor modulator in a rat model of postmenopausal osteoporosis. J Bone Miner Metab 2019;37:243-55. 10.1007/s00774-018-0929-9.
Evaluation of ostarine as a selective androgen receptor modulator in a rat model of postmenopausal osteoporosis
Short-term ostarine treatment in a rat model of postmenopausal osteoporosis improved bone microstructure, including bone mineral density and bone volume density, particularly in femora over vertebrae, but did not enhance biomechanical properties. Intermediate and high doses showed similar effects, while the low dose was ineffective. Further research is needed to assess long-term efficacy and potential side effects.
You can read the abstract of this article at
https://pubmed.ncbi.nlm.nih.gov/29785666/.
At the age of 60, I look and feel better than I ever have in my entire life! Switching my health program and hormone replacement therapy regimen over to Genemedics was one of the best decisions Iāve ever made in my life! Genemedics and Dr George have significantly improved my quality of life and also dramatically improved my overall health. I hav...
Nick Cassavetes ,60 yrs old
Movie Director (āThe Notebookā, āJohn Qā, āAlpha Dogā), Actor and Writer
I am now in my mid-sixties and feel better than I did in my 20ās. Many people have commented that I actually look 20 years younger since I started the program at Genemedics.
Calling Dr. George has proven to be one of the best decisions I have made in my life. Doctors and society convince us that developing various health issues and negative sy...
Pamela Hill ,66 yrs old
Call 800-277-4041 for a Free Consultation
GenemedicsĀ® Health Institute is a global premier institute dedicated to revolutionizing health and medicine through healthy lifestyle education, guidance and accountability in harmony with functional medicine. Our physician-supervised health programs are personally customized to help you reach your health and fitness goals while looking and feeling better than ever.
© Copyright Genemedics Health Institute. All Rights Reserved. Privacy Policy.
STEPS AWAY FROM A YOUNGER. HEALTHIER YOU!
Call 800-277-4041 for a Free Consultation
What to expect during your consultation: